Non-invasive strategies to detect and track activated myeloid cells will facilitate disease diagnosis and monitoring in patients affected by neuroinflammatory disorders. Here, the authors present ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...

Everybody wants their investments to grow. For that reason, “growth” funds seem, on the surface, more appealing than those classified as “value.” However, those monikers can be deceiving. There’s a ...

Growth stocks outperformed their value counterparts for much of 2025, but that trend started to shift toward the end of the year. Value stocks have seen more consistent returns heading into 2026. They ...